Sign in Create account

Krishna Institute of Medical Sciences Limited

Healthcare · Healthcare Services

NSE: KIMS BSE: 543308
₹705.45
▼ -30.80 (-4.18%)
Oct. 5, 2026 · NSE · nse_bhavcopy
Quality
47/100
Moderate
Valuation
—/100
Expensive
Momentum
26/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹29,629 Cr
PE (TTM)
105.1
Industry median 48.2 (44 companies)
Price to Book
11.6
PEG (TTM)
-9.8
Institutions holding %
49.17%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
-9.0
Relative return vs Sector, qtr %
-8.8
Free Cash Flow
₹-917 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
12.93%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-10.86%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
26.68%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
13.10%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
29.51%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
0.76
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
1.27
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
4.65
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
13.75%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
25.14%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
25.43%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
3.12%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
8.19%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
9.46%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • No Debt to equity is below 0.5 (1.27)
  • No Return on equity is 15% or more (9.5%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (10.3% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.2%
Low 700.0500 · High 747.8500
1W return
-8.0%
Low 700.0500 · High 781.7500
1M return
-7.7%
Low 700.0500 · High 819.0000
52W return
-2.3%
Low 575.8000 · High 858.0000
Lifetime High ₹2735.9000 (Sept. 12, 2024)
Lifetime Low ₹508.4500 (March 5, 2025)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
739.8
10D
756.1
20D
766.6
50D
775.4
100D
765.1
200D
720.3

Delivery and volume

Day avg. delivery
55.6%
Week avg. delivery
67.1%
Month avg. delivery
65.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

717.78
Pivot
First resistance735.52
Second resistance765.58
Third resistance783.32
First support687.72
Second support669.98
Third support639.92
Day RSI28.2
Day MFI39.2
Day MACD-10.42
Day MACD signal-3.55

Beta

1M0.16
3M0.43
1Y0.75
3Y0.67

Price change analysis

↓ -7.7%
Over 1 Month
LowHigh
700.05819.00
↓ -14.4%
Over 3 Months
LowHigh
700.05831.00
↑ 12.6%
Over 6 Months
LowHigh
618.55858.00
↓ -2.3%
Over 1 Year
LowHigh
575.80858.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 105.1 (own history: 24.5–121.4)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹484 Cr
Net profit (June 30, 2026)
₹66 Cr
Basic EPS (June 30, 2026)
₹1.6600

Ranks #8 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter32.50%
  • Mutual funds28.52%
  • FII/FPI14.74%
  • Other DII5.91%
  • Public18.33%

Largest holders

NameCategoryShares %Shares
Bhaskara Rao BollineniPromoter25.0200%105099645
Bluebridge Capital Private LimitedPromoter5.7600%24203310
Sbi Small Cap FundPublic5.1700%21694452
Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap FundPublic4.5000%18905009
Hdfc Small Cap FundPublic3.9800%16727825

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 32.50% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 14.44% to 14.74% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 28.70% to 28.52% in Jun 2026 qtr

42 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 32 insider trades, 13 SAST, 13 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
27 Sep 2024 Bhaskara Rao Bollineni Promoter Pledge Revoke 0 ₹35.00 Cr
18 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge Revoke 0 ₹8.50 Cr
18 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge Revoke 0 ₹7.00 Cr
18 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge Revoke 0 ₹21.00 Cr
4 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge 0 ₹8.00 Cr
4 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge 0 ₹19.00 Cr
4 Jun 2024 Bhaskara Rao Bollineni Promoter Pledge 0 ₹6.00 Cr
2 Mar 2024 Bollineni Seenaiah Naidu Promoter group Pledge Revoke 0 ₹7.79 Cr
2 Mar 2024 Bollineni Seenaiah Naidu Promoter group Pledge Revoke 0 ₹32.08 Cr
2 Mar 2024 Bhaskara Rao Bollineni Promoter Pledge 0 ₹22.00 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 47 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
5 Sep 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 245,154 738.1000 NSE
5 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 245,154 738.1000 NSE
2 Sep 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 501,458 727.5000 NSE
2 Sep 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 501,458 727.5000 NSE
29 Aug 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 251,598 737.4000 NSE
29 Aug 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 251,598 737.4000 NSE
28 Aug 2024 INFINITY PARTNERS Block Buy 1,570,000 2497.0000 NSE
28 Aug 2024 EMERALD INVESTMENTS LIMITED Block Sell 1,570,000 2497.0000 NSE
20 Aug 2024 SBI LIFE INSURANCE COMPANY LIMITED Block Buy 62,061 2373.3000 BSE
20 Aug 2024 DYNAMIC INDIA FUND S4 US I Block Sell 62,061 2373.3000 BSE

All bulk and block deals →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
3 Aug 2026 Financial Results Yes
13 Jun 2026 Fund Raising/Other business matters —
15 May 2026 Financial Results Yes
11 Mar 2026 Fund Raising/Other business matters —
6 Feb 2026 Financial Results Yes

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
15 Sep 2026 Company Update Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Sep 2026 Company Update Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 Sep 2026 Company Update Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (29.5%)

Weaknesses

  • Low Return on Equity (9.5%)
  • High financial leverage (Debt/Equity 1.27)
  • Tight liquidity (Current Ratio 0.76)

Opportunities

  • RSI in oversold territory (28.2) -- a technical rebound zone

Threats

  • PE above 35 (105.1) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Krishna Institute of Medical Sciences Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.